Added to YB: 2026-10-07
Pitch date: 2026-10-02
IDXX [neutral]
IDEXX Laboratories, Inc.
+5.93%
current return
Author Info
Forensic Alpha Research shares forensic equity research for investors who care more about avoiding permanent loss than chasing consensus upside. Sign up for the newsletter.
Company Info
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
Market Cap
$41.3B
Pitch Price
$516.57
Price Target
590.00 (+8%)
Dividend
N/A
EV/EBITDA
25.37
P/E
36.84
EV/Sales
9.26
Sector
Health Care Equipment and Supplies
Category
value
Compounder Watchlist, Edition 1: Ten Names, One Below Its Range - IDEXX Laboratories, Inc.
IDXX (monitor): At $518.77, IDEXX trades at 36.5x trailing earnings and just 2.1% below the midpoint of its $470-$590 fair-value range, leaving a thin margin of safety despite a 32.6% drawdown. CAG Diagnostics recurring revenue grew 10.3% organically, including about four points from price, leaving volume growth near six points; management also flagged soft US clinic visits, while ex-price recurring volume growth is the dominant variable.
Read full article (1 min)